Circulating fibroblast growth factor 21 levels in gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis
Abstract Background The connection between fibroblast growth factor 21 (FGF21) and the likelihood of gestational diabetes mellitus (GDM) or preeclampsia (PE) has received more attention recently. Based on published articles, meta-analysis were conducted to explore the differences in FGF21 levels in...
Saved in:
Main Authors: | Zhen Cao, Zhiming Deng, Jieyi Lu, Ying Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12884-025-07157-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Placental Vimentin Expression in Preeclampsia and Gestational Diabetes Mellitus
by: Fırat Asir, et al.
Published: (2024-04-01) -
The Role of Physical Activity in Pregnancy: Impact on Preeclampsia, Gestational Diabetes Mellitus, and Labor Outcomes
by: Paulina Woźniak, et al.
Published: (2025-02-01) -
The Impact of Gestational Diabetes Mellitus on the Development of Preeclampsia in Twin Pregnancies: A Retrospective Cohort Study Conducted at a Tertiary Hospital
by: Wu H, et al.
Published: (2025-01-01) -
Studies on the Association of GCK and GCKR Polymorphisms with Susceptibility to Gestational Diabetes Mellitus: A Meta-Analysis
by: Hongxia Tu, et al.
Published: (2025-01-01) -
Role of the serum levels of the inter-organs messenger fibroblast growth factor 21 (FGF21) in the diagnosis and prognosis of breast cancer patients
by: Stella Maris Ranuncolo, et al.
Published: (2025-01-01)